Regulus Therapeutics RGLS 深 沪
已收盘 06-25 16:00:00 美东时间
8.16
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 8.16
- 总市值 5.65亿
- 52周最高 8.345
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.8301
- 委 比 0.00%
- 总股本 6923.41万
- 历史最高 3072.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.76
- 每 手 1
- 风险率 2.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多诺华接近达成协议，拟以每股超70美元收购美国生物技术公司Avidity Biosciences
援引一位知情人士消息报道，瑞士诺华公司接近以每股超 70 美元的价格收购美国生物科技企业 Avidity 生物科学公司，该知情人士称交易公告最早或于周日发布...
2025-10-27 00:07
UPDATE 2-Novartis weighs deal for biotech Avidity Biosciences, FT reports
Adds details from the report in paragraphs 3-5, background from paragraph 7 onward Aug 6 (Reuters) - Swiss drugmaker Novartis NOVN.S has approached U.S. biotech Avidity Biosciences RNA.O for a potenti...
2025-08-06 23:37
Regulus Acquired by Novartis, Delisted from Nasdaq
Regulus ( ($RGLS) ) has issued an update. Regulus Therapeutics Inc. has been ac...
2025-06-25 21:29
单日暴涨130%+，肾病领域再成行业焦点
转自：新康界 4月30日，诺华公司宣布以17亿美元收购美股上市医药公司Regulus(NASDAQ:RGLS)，受此消息影响，Regulus的股价...
2025-06-23 19:50
BRIEF-Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
June 23 (Reuters) - Novartis AG NOVN.S: NOVARTIS ANNOUNCES EXPIRATION OF HART-SCOTT-RODINO WAITING PERIOD OF REGULUS THERAPEUTICS TENDER OFFER EXPIRATION OF HART-SCOTT-RODINO ACT WAITING PERIOD OCCURR...
2025-06-23 13:02
Preston Klassen, President & Head of R&D, Reports Acquisition of Common Shares in Regulus Therapeutics Inc
Preston Klassen, President & Head of R&D at Regulus Therapeutics Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: Thi...
2025-06-05 05:00
Regulus Therapeutics to be Acquired by Novartis
Regulus Therapeutics Inc ( ($RGLS) ) has released its Q1 earnings. Here is a br...
2025-05-09 12:59
Regulus Therapeutics Q1 EPS $(0.15) Beats $(0.24) Estimate
Regulus Therapeutics (NASDAQ:RGLS) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.24) by 37.5 percent. This is a 48.28 percent increase over losses of $(0.29) per share
2025-05-09 04:58
